Phase 3 clinical study of AK-120 in patients with herpes zoster

Trial Profile

Phase 3 clinical study of AK-120 in patients with herpes zoster

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Famciclovir (Primary)
  • Indications Herpes zoster
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Asahi Kasei Pharma Corp
  • Most Recent Events

    • 10 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top